Insider at SOPH plans sale of 20,000 shares

Jurgi Camblong filed a notice to sell 20,000 common shares of SOPH through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate sale amount of $113,800.00, expected on August 4, 2026 on NASDAQ.

Rhea-AI Filing Summary

Jurgi Camblong filed a notice to sell 20,000 common shares of SOPH through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate sale amount of $113,800.00, expected on August 4, 2026 on NASDAQ.

The filing also lists prior Rule 10b5-1 sales of SOPH common stock over the past three months, including 20,000 shares for $132,654.00 on July 21, 2026 and 65,269 shares for $398,632.27 on June 30, 2026, along with several additional transactions in May–July 2026.

Key Figures

Planned shares to be sold: 20,000 shares Planned aggregate sale amount: $113,800.00 Recent 10b5-1 sale 07/21/2026: 20,000 shares; $132,654.00 +3 more

6 metrics

Planned shares to be sold 20,000 shares Common shares covered by the notice for expected sale on August 4, 2026

Planned aggregate sale amount $113,800.00 Aggregate amount for the 20,000 SOPH common shares planned for sale

Recent 10b5-1 sale 07/21/2026 20,000 shares; $132,654.00 SOPH common shares sold under a Rule 10b5-1 plan on July 21, 2026

Recent 10b5-1 sale 06/30/2026 65,269 shares; $398,632.27 SOPH common shares sold under a Rule 10b5-1 plan on June 30, 2026

Recent 10b5-1 sale 07/20/2026 24,381 shares; $153,445.04 SOPH common shares sold under a Rule 10b5-1 plan on July 20, 2026

Founder shares acquisition date 03/18/2021 Date associated with founders shares listed as securities to be sold

Key Terms

Rule 10b5-1, founders shares, Executive Financial Services, Form 144

4 terms

Rule 10b5-1 regulatory

"10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

founders shares financial

"Common | 03/18/2021 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being planned for SOPH in this Form 144?

The filing plans a sale of 20,000 common shares of SOPH with an aggregate amount of $113,800.00, expected to be executed on August 4, 2026 through Morgan Stanley Smith Barney LLC on NASDAQ.

Who is the selling security holder in the SOPH Form 144 notice?

The selling security holder is Jurgi Camblong, who filed to sell 20,000 SOPH common shares and reported multiple prior Rule 10b5-1 sales of SOPH stock over the last three months under a trading plan.

How many SOPH shares are covered by the planned sale and at what amount?

The planned transaction covers 20,000 SOPH common shares with a stated aggregate sale amount of $113,800.00. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

What recent 10b5-1 sales of SOPH stock has Jurgi Camblong reported?

Recent Rule 10b5-1 sales include 20,000 shares for $132,654.00 on July 21, 2026 and 65,269 shares for $398,632.27 on June 30, 2026, plus several additional transactions in May, June, and July 2026.

What type of SOPH securities are being sold under this notice?

The notice covers sales of common shares of SOPH. The Form 144 indicates that 20,000 common shares are planned for sale and references earlier sales of SOPH common stock under a Rule 10b5-1 trading plan.

When were the SOPH founder shares originally acquired?

The document identifies founders shares of SOPH acquired on March 18, 2021. These founder shares are listed as the securities to be sold, with 20,000 shares specified in the Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:37 PM Accepted by SEC EDGAR 08/04/2026 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	JURGI CAMBLONG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	113800.00	85127825	08/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2021	Founders Shares	Issuer			20000	03/18/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/21/2026	20000	132654.00
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/20/2026	24381	153445.04
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/10/2026	8500	47791.25
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/07/2026	17685	93327.28
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	22486	118163.93
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/30/2026	65269	398632.27
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/29/2026	18410	108058.02
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/26/2026	50069	290329.01
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/25/2026	1373	7826.10
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/10/2026	8500	44500.90
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/19/2026	4486	20657.58
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/11/2026	8500	43241.20

144: Remarks and Signature

Remarks
Date of Notice	08/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jurgi Camblong
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)